{"id":"differin-0-3-topical-gel","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Erythema (redness)"},{"rate":"15-25","effect":"Dryness and peeling"},{"rate":"10-15","effect":"Irritation"},{"rate":"5-10","effect":"Photosensitivity"}]},"_chembl":{"chemblId":"CHEMBL2108694","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Adapalene selectively activates retinoic acid receptor gamma (RARγ) and other retinoid receptors, promoting keratinocyte differentiation and reducing comedone formation. It decreases sebum production and has anti-inflammatory properties that help resolve acne lesions. The 0.3% gel formulation represents a higher-strength topical delivery for enhanced efficacy in moderate acne.","oneSentence":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation in acne.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:24.635Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris (moderate severity)"}]},"trialDetails":[{"nctId":"NCT05582434","phase":"EARLY_PHASE1","title":"Experience With Topical Acne Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-02-15","conditions":"Acne","enrollment":72},{"nctId":"NCT01213199","phase":"PHASE2","title":"Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-03","conditions":"Acne Scars","enrollment":20},{"nctId":"NCT03650361","phase":"PHASE3","title":"Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Aleor Dermaceuticals Limited","startDate":"2018-09-17","conditions":"Acne Vulgaris","enrollment":755},{"nctId":"NCT01231334","phase":"PHASE4","title":"A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-08","conditions":"Acne Vulgaris","enrollment":286},{"nctId":"NCT01095640","phase":"NA","title":"Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel","status":"COMPLETED","sponsor":"Actavis Mid-Atlantic LLC","startDate":"2009-03","conditions":"Acne Vulgaris","enrollment":1159}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Differin 0.3% Topical Gel","genericName":"Differin 0.3% Topical Gel","companyName":"Aleor Dermaceuticals Limited","companyId":"aleor-dermaceuticals-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation in acne. Used for Acne vulgaris (moderate severity).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}